Exploiting ING2 Epigenetic Modulation as a Therapeutic Opportunity for Non-Small Cell Lung Cancer - Université de Rennes Access content directly
Journal Articles Cancers Year : 2019

Dates and versions

hal-02365418 , version 1 (10-07-2020)

Licence

Attribution

Identifiers

Cite

Alice Blondel, Amine Benberghout, Remy Pedeux, Charles Ricordel. Exploiting ING2 Epigenetic Modulation as a Therapeutic Opportunity for Non-Small Cell Lung Cancer. Cancers, 2019, 11 (10), pp.E1601. ⟨10.3390/cancers11101601⟩. ⟨hal-02365418⟩
40 View
62 Download

Altmetric

Share

Gmail Facebook X LinkedIn More